Michael Redman

Michael Redman

Verkställande Direktör på
Theratome Bio, Inc.
71 år
Health Technology
Commercial Services
Consumer Services

Profil

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc., founded in 2001, where the title held was Chief Executive Officer from 2001 to 2005.
Mr. Redman was the founder of Oncolix, Inc., founded in 2006, where the title held was Chief Executive Officer & Director.
Mr. Redman is currently Chief Executive Officer at Theratome Bio, Inc. Mr. Redman is currently Chief Executive Officer & Director at GreenJay Therapeutics, Inc., starting in 2022.
Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc.; Chief Executive Officer at Botanix Pharmaceuticals Ltd.; Director at Oncolix, Inc. from 2006 to 2019; Principal at Wyeth LLC; Principal at Repros Therapeutics, Inc.; Principal at Aronex Pharmaceuticals, Inc.; Chief Operating Officer & Executive Vice President at Genprex, Inc. from 2020 to 2021; Member at Licensing Executives Society; and Principal at Biovail Pharmaceuticals LLC.
Education includes undergraduate studies at the University of Missouri and an MBA from the University of Phoenix.

Aktiva positioner av Michael Redman

FöretagPositionStart
Verkställande Direktör -

Tidigare kända positioner av Michael Redman

FöretagPositionSlut
GENPREX, INC. Verksamhetschef 2021-10-15
ONCOLIX, INC. Verkställande Direktör -
Verkställande Direktör 2005-01-01
Företagsledare/Principal -
Verkställande Direktör -
Se detaljerna i Michael Redmans erfarenhet

Michael Redmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

26

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Michael Redman